BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 6326518)

  • 1. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.
    Strada SJ; Martin MW; Thompson WJ
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
    Hait WN; Weiss B
    Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
    [No Abstract]   [Full Text] [Related]  

  • 3. Proteolytic activation of Ca2+-dependent cyclic nucleotide phosphodiesterase from Escherichia coli.
    Iwasa Y
    Horm Metab Res; 1981 Jul; 13(7):414-5. PubMed ID: 6268507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
    Ilien B; Landry Y
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
    Davis CW; Daly JW
    Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
    [No Abstract]   [Full Text] [Related]  

  • 6. Stimulation of cyclic nucleotide phosphodiesterase by products of phosphatidylinositol metabolism catalyzed by phospholipase A2.
    Tai HH; Tai CL
    Arch Biochem Biophys; 1982 Apr; 214(2):622-7. PubMed ID: 6284032
    [No Abstract]   [Full Text] [Related]  

  • 7. Membraneous and cytosolic cyclic-nucleotide phosphodiesterases in beef aorta: substrate specificity, endogenous inhibition and activation [proceedings].
    Ilien B; Morel A; Stierle A; Landry Y
    Arch Int Physiol Biochim; 1978 Oct; 86(4):865-7. PubMed ID: 84582
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
    Hidaka H; Endo T
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
    [No Abstract]   [Full Text] [Related]  

  • 9. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, characterization and Ca2+ and calmodulin regulation of cyclic nucleotide phosphodiesterases from human placentae of different ages.
    Tertrin-Clary C; Chenut MC; Acker G; De La Llosa P
    Biochem Int; 1989 Jan; 18(1):99-117. PubMed ID: 2541726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Ca2+ and calmodulin on enzymes of cyclic nucleotide metabolism in ox neurohypophyseal secretosomes.
    Dartt Da; Torp-Pedersen C; Thorn NA
    Ann N Y Acad Sci; 1980; 356():369-70. PubMed ID: 6112949
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the rabbit myometrium].
    Osipenko AA; Prishchepa LA; Kurskiĭ MD
    Ukr Biokhim Zh (1978); 1986; 58(4):26-31. PubMed ID: 3016961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative kinetic study of bovine calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes utilizing cAMP, cGMP and their 2'-O-anthraniloyl-,2'-O-(N-methylanthraniloyl)-derivatives as substrates.
    Grewal J; Karuppiah N; Mutus B
    Biochem Int; 1989 Dec; 19(6):1287-95. PubMed ID: 2561449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
    Hoskins B; Luong HB
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cyclic nucleotide phosphodiesterase activity.
    Vaughan M; Danello MA; Manganiello VC; Strewler GJ
    Adv Cyclic Nucleotide Res; 1981; 14():263-71. PubMed ID: 6169258
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and properties of cyclic nucleotide phosphodiesterases.
    Beavo JA; Hansen RS; Harrison SA; Hurwitz RL; Martins TJ; Mumby MC
    Mol Cell Endocrinol; 1982; 28(3):387-410. PubMed ID: 6185373
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat.
    Levin RM; Weiss B
    Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of multiple forms of cyclic nucleotide phosphodiesterase from bovine hypothalamus: new factors modulating enzyme activity.
    Galoyan AA; Gurvitz BYa
    Neurochem Res; 1985 Nov; 10(11):1467-81. PubMed ID: 3003614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin-stimulated cyclic nucleotide phosphodiesterases in plasma membranes of bovine epididymal spermatozoa.
    Chaudhry PS; Casillas ER
    Arch Biochem Biophys; 1988 May; 262(2):439-44. PubMed ID: 2835007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic nucleotide analogs used to study phosphodiesterase catalytic and allosteric sites.
    Erneux C; Miot F
    Methods Enzymol; 1988; 159():520-30. PubMed ID: 2842616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.